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ABSTRACT
Poisoning by Botulinum Neurotoxins (BoNTs) leads to the severe neuroparalytic
illness known as botulism, which is characterized by flaccid paralysis, respiratory failure,
and death. BoNTs are the most acutely toxic substances on the planet, so detection at
physiologically relevant concentrations is difficult. Because current treatments for
botulism cannot reverse existing paralysis, rapid detection is key, and current diagnostic
techniques are not meeting this need. We have developed a flow-based assay platform
that allows for detection of the Light Chain of BoNT/A as well as a means to study the
action of the toxin on its protein substrate in a system that mimics many aspects of a
physiologically relevant environment. The total assay time has been reduced to
approximately 20 hours, and this platform has multiplex and high throughput screening
capabilities for drug discovery.

	
  

v

TABLE OF CONTENTS
CHAPTER 1

1

INTRODUCTION
1.1 Overview and Project Aims
1.2 Membrane Docking and Vesicle Fusion
1.3 Proposed Mechanism of SNARE Cleavage by BoNTs
1.4 Overview of Flow-Based Assays
1.4 Summary of Previous Research
1.6 Overview of Thesis

1
1
2
5
8
10
13

CHAPTER 2

14

SNAP-25 CONSTRUCT DESIGNS AND PURIFICATION
2.1 Introduction
2.2 Purification of SNAP-25 GFP
2.2.1 SNAP-25 GFP Construct Design
2.2.2 Transformation and Expression
2.2.3 Purification on the FPLC
2.2.4 Discussion
2.3 Purification of SNAP-25 T-Sapphire (TS)
2.3.1 SNAP-25 TS Construct Design
2.3.2 Transformation and Expression
2.3.3 Optimization of Buffering Conditions
2.3.4 Purification on the FPLC
2.3.5 Discussion
2.4
Chapter Summary and Conclusions

14
14
17
17
19
20
23
23
23
26
28
31
34
37

CHAPTER 3

37

ASSAY DESIGN AND ATTACHMENT OF SNAP-25 TO MICROSPHERES
3.1 Introduction
3.2 Attachment Strategy of SNAP-25 to Lipid-Coated Microspheres
3.3 Materials and Methods
3.3.1 Lipid Preparation
3.3.2 Characterization of Microspheres using Flow Cytometry
3.3.3 Formation of Lipid Bilayers around Microspheres
3.3.4 Bovine Serum Albumin (BSA) Blocking
3.3.5 Conjugation of SNAP-25 to MPB-PE

37
37
40
44
44
46
49
52
55

	
  

3.3.6 Incubation with Protease
3.3.7 Flow Cytometric Analysis
3.4 Results
3.5 Discussion
3.6 Chapter Summary and Conclusions

vi

57
59
59
65
66

CHAPTER 4

67

SUMMARY AND FUTURE DIRECTIONS
4.1 Summary of Work
4.2 Future Directions

67
67
68

APPENDIX

73

REFERENCES

76

	
  

1

Chapter 1
INTRODUCTION
1.1

Overview and Project Aims
Botulism is a severe neuroparalytic disease, and the extreme lethality of
Botulinum Neurotoxins (BoNTs) make detection of the toxin challenging. The
lethal dose of BoNTs is very low (1 ng/kg), so it is difficult to measure the
presence of the toxin at physiologically relevant concentrations. In fact, current
diagnostics often rely on observing the onset of paralytic symptoms in the patient
[1]. For effective therapy, however, early detection is critical. Thus, there is a
need for fast, accurate in vitro assays capable of BoNT detection.
Previous work by Graves and coworkers has demonstrated that a
microsphere-based assay can be used to measure the presence of BoNT
proteolytic activity. [2] However, this existing approach does not present the
BoNT substrate in its fully natural, membrane-associated state, and therefore
cannot investigate the role played by membranes in controlling BoNT activity.
This limitation could be an important factor in both the detection of BoNT
enzymatic activity and in the use of this technology for drug-discovery screening.
The research reported in this thesis outlines steps towards the development
of a biomimetic, membrane-containing microsphere-based protease assay that can
detect the presence of BoNT/A using flow cytometry. By tagging a full-length
membrane-bound SNAP-25 protein substrate with a fluorophore located
downstream of the BoNT/A cleavage site, proteolytic cleavage can by observed
via loss of fluorescence after incubation with the toxin. Although not included in
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this study, these microsphere-based assays have the potential to be multiplexed
for cross-reactivity studies and are also capable of high throughput screening for
drug discovery purposes. Furthermore, there is much that is still unknown about
the interaction between BoNTs and SNARE proteins, and we hypothesize that the
membrane plays an important role in facilitating these interactions. Unlike current
BoNT detection systems, this assay design incorporates a lipid membrane in an
effort to better mimic a biologically relevant environment. Relevant background
information is presented in the remainder of this chapter, while the overall thesis
describes progress towards the goal of implementing a flow-based assay for
BoNT activity against membrane-bound substrates.

1.2

Membrane Docking and Vesicle Fusion
The

SNARE

(soluble

N-ethylmaleimide-sensitive

fusion

protein

attachment receptors) protein complex mediates cell-cell communication via the
highly coordinated trafficking and fusion of vesicles with a target compartment,
allowing neurotransmitter release [3]. The three SNARE proteins that are integral
to membrane fusion and docking are SNAP-25, VAMP, and syntaxin. SNAP-25
(25 kDa synaptosome-associated protein) is a soluble protein anchored in the
plasma membrane by palmitoyl groups attached to four cysteine residues on the
molecule [4]. VAMP (vesicle-associated membrane protein, also termed
synaptobrevin) is the integral synaptic vesicle membrane protein that contains a
COOH transmembrane domain that inserts into the vesicle bilayer [4,5]. Finally,
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syntaxin is a type II membrane protein that contains four α-helical regions and is
anchored to the membrane by a COOH-terminal transmembrane domain [4,5].
When these three proteins bind, they create a coiled four-helix bundled
SNARE complex. X-Ray crystallography and deep-etch electron microscopy
show that two SNAP-25 helices, one VAMP helix, and one syntaxin helix
intertwine in a parallel fashion (with all N-termini at the same end of the bundle)
to form this extremely stable four-helical core complex [6–10]. The free energy
release during formation of this four-helix bundle is enough to drive membrane
fusion (Figure 1.1) [4,5]. The widely accepted mechanism of fusion is that there is
a Ca2+ triggered ‘zippering’ effect of the SNARE motifs from the N termini to the
C-terminal membrane anchors, and this effect clamps the membranes together.
The mechanical forces during clamping are thought to be sufficient to overcome
the energy barrier for fusion, though the details of this mechanism are still unclear
[3].
After the fusion event occurs, the presynaptic vesicles are able to release
their contents into the synaptic cleft [6]. This overall process is essential for
nervous system function and health, as membrane fusion must be achieved for
chemical synaptic transmission to occur [6]. In the case of the SNARE protein
complex, acetylcholine-filled presynaptic vesicles fuse with the plasma membrane
and release their contents into the synaptic cleft. This acetylcholine (ACh) can
then bind receptors on skeletal muscle fibers and initiate muscle contractions
[6,10].

	
  

Figure 1.1 Mechanism of normal neurotransmitter release via vesicle docking and
membrane fusion. The SNARE bundle complex is formed by the binding of syntaxin,
synaptobrevin (also termed VAMP), and SNAP-25. This fusion allows for the release
of acetylcholine into the synaptic cleft at the neuromuscular junction. Figure adapted
from Binz et al. (2010) [11].
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After the vesicle contents are released, a recycling pathway is initiated
where the SNARE core complex is disassembled into its monomeric components.
This disassembly is dependent on ATP and the adaptor protein α-SNAP (soluble
NSF attachment protein) [6]. Because the four-helix SNARE bundle is
exceptionally stable, disassociation requires a large amount of metabolic energy.
This energy is provided by N-ethylmaleimide sensitive fusion protein (NSF),
which is recruited by bound α-SNAP [3,6]. Subsequent hydrolysis of ATP by
NSF causes dissociation of the SNARE complex and vesicle exocytosis [6,7]. By
this mechanism of vesicle docking/fusion and recycling, neurotransmission is
achieved and nervous system function is maintained.

1.3

Proposed Mechanism of SNARE Cleavage by BoNTs
The botulinum neurotoxin (BoNT) is one of the most toxic substances
known, with a 50% lethal dose for susceptible humans of approximately 1 ng/kg
of body weight [11,12]. BoNTs are secreted by the anaerobic bacterium
Clostridium botulinum and are composed of a heavy chain (~100 kDa) and light
chain (~50 kDa) [5,11,13,14]. The toxins are ingested and taken up by epithelial
cells, where they eventually reach the motor nerve terminals [11]. They are then
taken up by the recycling pathway of synaptic vesicles via four main steps: first,
they bind to ganglions at the surface of nonmyelinated nerves. Second, there is an
interaction with the synaptic vesicle receptors for BoNT/A (this process is heavychain mediated) [11]. Third, the vesicles are endocytosed, allowing intracellular
transport. The acidic environment during transport causes the heavy chain to
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undergo a conformational change and form a cation-selective channel. This pore
formation is thought to facilitate the passage of the catalytic domain from the
membrane into the cytosol [1]. The light chain also partially unfolds during this
step [11]. Finally, the light chain is released from the heavy chain to hydrolyze
peptide bonds of SNARE proteins in the cytosol. Each of the seven serotypes of
BoNT (A-G) have a unique specificity to its respective SNARE protein substrate
[14]. BoNT/A, for example, proteolyzes SNAP-25 by hydrolyzing the peptide
bond nine amino acids away from the C-terminus of the protein [11]. The
BoNT/A cleavage site and overall structure of SNAP-25 are shown in Figure 1.2.
The light chain of botulinum neurotoxin contains a highly conserved Zn2+
His-Glu-X-X-His binding motif, indicating that the proteolytic activity of BoNTs
is zinc-dependent [11]. Zn2+ ions are coordinated by the two histadines in this
motif, a water molecule that is bonded to the glutamate residue, and another Glu
that is located 35 amino acids downstream [11]. The catalytic mechanism is not
entirely known, but it is thought that the polar water molecule bonded to the Glu
residue coordinates a nucleophilic attack on the nitrogen atoms in the peptide
bond of the SNARE protein. Via this proteolytic mechanism, each of the seven
serotypes of BoNT specifically cleaves its respective SNARE protein substrate,
blocking neurotransmitter release and causing flaccid paralysis, respiratory
failure, and death.

	
  

Figure 1.2 Structure of SNAP-25. The protease cleavage site for the BoNT/A is
shown in red. The S1, S2, S3, and S4 domains represent the four copies of the nineresidue SNARE motif that is conserved amongst all three SNARE proteins. The
protein is anchored to the membrane via the palmitoyl groups attached to the four
cysteine residues (CCCC) in the middle of the protein. Figure adapted from Binz et al.
(2010) [11].
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Overview of Flow-Based Assays
Microsphere-based flow cytometric assays have a wide variety of
biomedical applications. Flow cytometry is a powerful tool that enables the
analysis of multiple samples simultaneously, making cross-reactivity studies
possible [15]. Modern flow cytometers are capable of analyzing thousands of
particles per second in “real time.” Because of this incredibly rapid analysis time,
flow cytometry is also often used for high throughput screening and drug
discovery studies [15]. Additionally, minimal sample volumes are required, and
flow cytometry can yield highly reproducible results [15].
Flow cytometry works by using sheath fluid to hydrodynamically focus a
sample stream into a very narrow channel [16]. The particles are focused into a
single-file line, where they are individually interrogated by a laser beam [16].
When the laser beam hits the particle, two types of measurements are produced.
First, a fluorescence measurement results from the emission light given off of the
particles when excited by the particular wavelength of the laser. Second, the
amount of light scattered from the particle is quantifiable and directly related to
both the size and density of the particle (larger, denser particles will scatter more
light than smaller particles) [16]. The light that is scattered in the forward
direction (forward scatter) is more indicative of cell size, while the light that is
scattered to the side (side scatter) is more indicative of density. These
fluorescence and scatter measurements are collected by a detector, where they can
then be analyzed using flow cytometry software. Figure 1.3 shows a schematic
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from Abcam depicting hydrodynamic focusing and particle interrogation in flow
cytometry [16] .

Figure 1.3 Illustration of hydrodynamic focusing and particle interrogation in flow
cytometry. Figure from Abcam [16].	
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Summary of Previous Research
Currently, the standard method (and only approved method) for positive
confirmation of BoNTs is the mouse lethality bioassay, in which dilutions of the
suspect material are injected into mice. The relationship between survival time
and toxin concentration can then be plotted as a standard curve [1,12,17]. While
this method has demonstrated a low limit of detection (LOD) in the picomolar
range, it has many limitations [12]. First, this clinical diagnosis of botulism relies
on the patient’s development of symptoms, which limits the effectiveness of
treatment [1]. Second, the mouse bioassay is labor intensive and takes two to four
days to perform. The current treatment for botulism is the administration of
equine antitoxin, which cannot reverse existing paralysis due to its inability to
cross the nerve membrane and neutralize the toxin in already affected cells [1].
Because of this, early detection is key, and current methods do not meet the
clinical need for an accurate and rapid diagnosis. Immunoassays such as ELISA
can also be used for BoNT detection, but these assays are not high throughput, not
capable of being multiplexed, and detect only the presence of BoNT without
providing any information on the enzymatic activity of the neurotoxin [1,12]. A
summary of the performance of current diagnostic techniques for BoNT is shown
in Table 1.1.
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Table 1.1 Summary of current techniques for BoNT detection. Table adapted from Cai
et al. (2007) [1].

Many in vitro methods for BoNT detection are under development, but
none have yet been approved for clinical use [17]. For example, gold
nanoparticles (AuNPs) have been biofunctionalized with peptides that mimic
SNAP-25. The proteolytic cleavage of these peptides by BoNT/A alters how the
AuNPs aggregate, leading to changes in how the nanoparticles interact with light,
so BoNT detection can be achieved by colorimetric sensing [12]. While this assay
greatly reduces detection time for BoNT/A compared to the mouse lethality assay
(the overall assay time is about 4 hours), it does not incorporate a full-length
SNAP-25 substrate or a lipid membrane, so it is limited in terms of providing
information on how the protease acts on a membrane protein in a fully
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biologically relevant environment. Cellular-based assays are also utilized for
BoNT detection. PC-12 neuronal cells or spinal chord cultures can be used to
monitor the inhibition of neurotransmitter release when exposed to BoNTs [1].
While this method does provide information on the overall enzymatic activity of
BoNTs in a physiologically relevant environment, it also has many disadvantages.
First, these cell-based assays take at least 2-3 days to perform, which again limits
the need for rapid diagnosis. Maintaining the cell lines is also both labor-intensive
and expensive, and the assay itself is complicated and difficult to perform [1].
Cellular assays are also low throughput and incapable of multiplex studies.
The flow-based assay platform described in this thesis addresses many of
the limitations of current BoNT detection techniques. First, the required detection
time is significantly shorter than many of the current techniques, with the entire
assay taking approximately 24 hours. Second, it is the only membrane-containing
method available that is capable of both multiplexing and high throughput
screening, allowing the possibility of cross-reactivity studies and drug screening
capabilities. Because the membrane may play an important role in mediating
BoNT activity, it is important to incorporate a lipid bilayer to better resemble a
biological environment when doing drug screening and detection studies.
Previous research by Graves and coworkers used biotinylated, full-length
SNAP-25 directly bound to streptavidin microspheres for BoNT/A Light Chain
(LC) detection via flow cytometry [2]. The SNAP-25 protein is tagged with a
fluorescent molecule at the C terminus (after the protease cleavage site), so the
presence of BoNT is indicated by loss of fluorescence once the protease cleaves

	
  

13

off this fluorophore [2]. This assay design is described in detail in Chapter 3.
While this previous microsphere-based assay platform is capable of highthroughput screening and multiplex studies, it still lacks a lipid membrane.
Because SNARE proteins are all either membrane or membrane-associated
proteins, we hypothesize that the membrane plays a critical role in facilitating the
interaction between BoNTs and SNARE protein cleavage. In order to better
mimic a natural environment, we propose to develop a microsphere-based
protease assay for detection of BoNT/A LC that incorporates a full-length SNAP25 substrate and a lipid membrane. Our expectation is that this system will
provide a means to detect BoNT activity against substrates presented in a more
natural environment and also provide a means to study the role played by
membranes in mediating the overall neurotoxin activity.

1.6

Overview of Thesis
In the remainder of this thesis, the following results are presented. Chapter
2 describes the construct designs, expression, and purification of the two fulllength SNAP-25 constructs used in this study: SNAP-25 GFP and SNAP-25 TSapphire. The membrane-based assay design, experimental methods, initial assay
results using SNAP-25 GFP, and data analysis methods are all described in
Chapter 3. Finally, a summary of this research and indication of future work are
presented in Chapter 4.
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Chapter 2
SNAP-25 CONSTRUCT DESIGNS AND PURIFICATION

2.1

Introduction
Two constructs of full-length SNAP-25 were used in this study. The first
construct is tagged with green fluorescent protein (GFP) at the C terminus. GFP
was initially chosen as the detection fluorophore for these assays for several
reasons. First, an extensive body of literature exists that use full-length SNAP-25
tagged with GFP, and this construct has been shown to be very stable under
physiological conditions [4,18,19]. Second, biotinylated SNAP-25 GFP has been
used historically in the Graves lab [2], so the SNAP-25 GFP plasmid was already
synthesized and readily available in UNM’s Center for Biomedical Engineering.
The majority of the data presented in this thesis uses the biotinylated SNAP-25
GFP construct. However, in an important new direction, progress is underway to
move to a new chromophore, T-Sapphire (TS). The TS fluorophore is a GFP
mutant with many advantages over GFP. The four amino acid mutations that
create TS (Q69M\C70V\V163A\S175G) facilitate improved folding relative to
GFP while maintaining a comparable quantum yield, extinction coefficient, and
pKa [20]. Additionally, TS has a Stokes Shift approximately 5 times larger than
that of GFP (112 nm compared to 21 nm). Because the ability to distinguish
between excitation and emission light is imperative in fluorescence-based studies,
a larger Stokes Shift is preferable. Also, the use of TS allows use of the deep blue
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and UV excitation sources found on many commercial cytometers. Figure 2.1
compares the GFP and T-Sapphire spectra.
In this chapter, the construct designs, expression, and purification of both
SNAP-25 GFP and T-Sapphire are described. Because SNAP-25 TS is a new
construct, the purification process has required, and is still undergoing, a great
deal of optimization. Initial attempts at purification are presented in this chapter,
and preliminary data that shows binding of the SNAP-25 T-Sapphire protein to
lipid-coated microspheres is shown in Chapter 4. Again, the majority of the
experiments presented in the following chapters are carried out using the SNAP25 GFP construct, which will lay the groundwork for future, detailed comparison
of the performance of these two proteins.

	
  

Figure 2.1 Spectral comparison of T-Sapphire (blue) and GFP (green). The dashed
lines represent excitation and the solid lines show emission. GFP is excited optimally
near 488 nm and emits at 509 nm, while T-Sapphire is excited optimally near 399 nm
and emits at 511 nm. Figure adapted from Zapata-Hommer et al. (2003) [20].

16
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2.2

Purification of SNAP-25 GFP

2.2.1

SNAP-25 GFP Construct Design
The SNAP-25 GFP plasmid was made previously by the Graves group and
coworkers. The EGFP was cut from the pEGFP-N2 plasmid (Clonetech) using the
restriction enzymes BamHI and SacI [2]. The full-length SNAP-25 construct was
cloned in a SNAP-25 clone plasmid (Open Biosystems) using polymerase chain
reaction, and the ligated PCR product was also digested with BamHI and SacI [2].
This SNAP-25 was then inserted into the PinPoint Xa-1 vector (Promega)
between the biotin tag and the EGFP. This vector has a T7 promoter and is
inducible with Isopropyl β-D-1-thiogalactopyranoside (IPTG). The plasmid
contains a gene for ampicillin (or carbenicillin (CARB)) resistance [2]. Figure 2.2
depicts a map of the SNAP-25 GFP plasmid and its features (figure made using
SerialCloner). The complete plasmid sequence is listed in the appendix [2,21].

	
  

Figure 2.2 Map of the full-length SNAP-25 GFP plasmid in the Pinpoint Xa-1 vector.
The SNAP-25 sequence (pink) is located between the biotin tag (dark blue) and the
EGFP (light green). Figure made using SerialCloner.
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Transformation and Expression
The SNAP-25 GFP plasmid was transformed into competent AVB-101 E.
coli cells from Avidity. This cell line was chosen for the expression of SNAP-25
GFP because it contains the pACYC184 plasmid (maintained by chloramphenicol
(CAM)), which has been engineered to express an inducible BirA gene [17]. BirA
is a biotin ligase that catalyzes in vitro, site-specific enzymatic biotinylation [17].
In other words, the AVB-101 cell line has been optimized for the expression of
biotinylated proteins. While production of biotinylated protein is not essential for
the present work, it was needed for the previous work that involved attachment of
protein to streptavidin-coated microspheres [2]. Its use was continued here due to
this past experience in protein expression and purification using this cell line and
biotinylated protein.
The transformed bacteria were grown on Lysogeny Broth (LB) media
plates containing 34 µg/ml of chloramphenicol (CAM) and 50 µg/ml CARB. A
single colony from the transformation was collected and grown up in 3 ml of
autoclaved Terrific Broth (TB) media (again containing 34 µg/ml of CAM and 50
µg/ml CARB) at 37°C overnight, shaking at 250 rpm. This overnight culture was
then used to inoculate 250 ml of sterile TB media (with 34 µg/ml of CAM and 50
µg/ml CARB). 40 mM biotin was added, and the culture was allowed to grow for
an additional 2-3 hours in the 37°C incubator, shaking at 250 rpm. When the
OD600 reached a value of ~0.6, 100 µM of IPTG was added to induce the
expression of the SNAP-25 GFP protein. After induction with IPTG, the
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temperature was reduced to 30°C, and the cells were grown overnight with the
shaker on at 250 rpm.
After this overnight incubation, the cells were harvested by centrifugation
at 3500 rpm for 30 minutes at 4°C. The supernatant was discarded, and the cell
pellet was resuspended in 40 ml of sterile 1X Phosphate Buffered Saline (PBS)
buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2mM KH2PO4, pH=7.4)
and stored frozen at -20°C. Upon subsequent use, the resulting freeze-thaw cycle
helps to lyse the cells.

2.2.3

Purification on the FPLC
The frozen cells in PBS were placed in a water bath at room temperature
until thawed. One milliliter of a broad-spectrum protease inhibitor cocktail
(Sigma-Aldrich) was added, and the solution was subsequently sonicated on the
probe sonicator for 15 minutes at 10 Watts to sufficiently lyse the cells. The cell
debris was extracted by centrifugation at 14,000 rpm for 30 minutes at 4°C. The
supernatant was then loaded into the injection column of the FPLC for
purification. The column contains SoftLink Avidin Resin (Promega), which binds
the biotinylated SNAP-25 GFP. The bound protein was then eluted off of the
column with a biotin elution buffer (1mM dithiothreitol (DTT) and 5mM biotin
dissolved in PBS and vacuum filtered, pH=7.4). DTT is a reducing agent and
helps ensure that the SNAP-25 GFP protein stays in the reduced form, thus
preventing crosslinking. Elution fractions (tubes that demonstrated green
fluorescence under UV illumination) were collected and spun down two times in
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molecular weight cut-off (MWCO) filter centrifuge tubes (EMD Millipore) for 12
minutes at 3500 rpm to further purify and concentrate the protein. Because the
size of SNAP-25 GFP is ~62 kDa, a MWCO filter of 30 kDa was chosen. The
protein retentate was then pipetted into dialysis tubing with a membrane MWCO
of 6,000–8,000 Da. Four rounds of dialysis were performed at 4°C, switching out
the dialysis buffer (3L of 50 mM HEPES and 100 mM NaCl, pH=7.4) every 4
hours. Protein purity was assessed by running a 10% SDS-PAGE protein gel
(Figure 2.3). Finally, the protein concentration was measured using the A280 (i.e.
the absorbance at λ= 280 nm) on the Nanodrop (Thermo Scientific).
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Figure 2.3 10% SDS-PAGE gel assessing the purity
of SNAP-25 GFP (63.8 kDa) after purification on
the FPLC and subsequent processing, as described in
the text. The arrow indicates the protein of interest.
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Discussion
The amount of protein produced from the purification (as calculated from
the A280 measurement on the Nanodrop) was 4 µM in a 2 ml volume. However,
the SDS-PAGE gel in Figure 2.3 reveals that the SNAP-25 GFP protein is not
completely pure (multiple protein bands are visible). These impurities can
potentially be problematic downstream when trying to couple the SNAP-25 GFP
to a lipid-coated microsphere. In order to address this concern and to minimize the
effects of nonspecific binding, blocking steps with Bovine Serum Albumin (BSA)
were incorporated into the coupling protocol (described in Chapter 3).

2.3

Purification of SNAP-25 T-Sapphire (TS)

2.3.1

SNAP-25 TS Construct Design
The SNAP-25 TS construct was designed in SerialCloner by mutating the
4 EGFP amino acids previously mentioned (Q69M\C70V\V163A\S175G) in the
full-length SNAP-25 GFP construct to create the SNAP-25 T-Sapphire mutant.
This sequence was inserted in the pET-15b vector (Novagen), which contains a
His-tag coding sequence. This vector also has a T7 promoter and has bacterial
resistance to ampicillin. The plasmid was prepared by GenScript. Figure 2.4
shows the SNAP-25 T-Sapphire plasmid and its relevant features. Copies of the
plasmid were made using a MaxiPrep kit from QIAGEN, and a restriction digest
was performed using the restriction enzyme BamHI to confirm that the plasmid
was sequenced correctly. Figure 2.5 shows an acrylamide gel of the restriction
digest.

	
  

Figure 2.4 Map of the full-length SNAP-25 T-Sapphire plasmid in the pET-15b
vector. The SNAP-25 sequence (pink) can be seen between the Histadine tag (light
blue) and the T-Sapphire fluorophore (dark blue). Figure made using SerialCloner.
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Transformation and Expression
The SNAP-25 TS plasmid was transformed into competent BL21 (DE3)
pLysS E. coli cells (Promega). This cell line is very commonly used for protein
expression of genes under control of a T7 promoter and contains the pLysS
plasmid, which is maintained by CAM. The transformation and induction of the
SNAP-25 TS plasmid were conducted under the exact same conditions and with
the same antibiotics as the SNAP-25 GFP, with the exception that no biotin was
added prior to induction (the SNAP-25 TS construct does not contain a biotin
tag).
To ensure that the protein was being expressed, 1 ml aliquots of the cell
culture were collected at various time points after induction and run on the PTI
fluorometer to observe fluorescence (Figure 2.6). Before measurement on the
fluorometer, the samples were diluted to obtain the same optical density at 600
nm. 24 hours after induction, an emission peak can be seen at 511 nm when
exciting at 399 nm, which is the spectral signature of the T-Sapphire fluorophore.
After an overnight incubation at 30°C shaking at 250 rpm, the cells were
harvested by centrifugation at 3500 rpm for 30 minutes at 4°C. The supernatant
was discarded, and the cell pellet was stored at -20°C.

	
  

Figure 2.6 Emission scan of SNAP-25 TS samples taken at various time points
after induction. Excitation for T-Sapphire is 399 nm, with an emission peak at 511
nm. The blue line represents the samples prior to induction, the red line is a sample
four hours after induction, and the green line is 24 hours after induction. The arrow
indicates the emission peak for the T-Sapphire fluorophore.
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Optimization of Buffering Conditions
As an initial step toward developing optimized purification protocols for
SNAP-25-TS, various approaches were explored using 5 ml columns packed with
Ni-NTA beads. These studies were carried out prior to FPLC purification
described in Section 2.3.4. The primary objective of these initial studies was to
optimize buffering conditions with the goal of minimizing the amount of
nonspecific binding during purification. In order to reduce nonspecific binding,
we needed to determine an optimal concentration of imidazole to use in the
equilibration buffer.
The equilibration buffer flows through the column after the protein of
interest has bound and is intended to wash away any other proteins that are
nonspecifically bound to the column. Equilibration buffers were prepared with
imidazole concentrations of 5 mM, 10 mM, and 20 mM in PBS (vacuum filtered,
pH=7.4). One protease inhibitor tablet (Roche) was added to each buffer, as well
as 2 mM beta-mercaptoethanol (BME). Like DTT, BME is a reducing agent that
prevents crosslinking. An elution buffer was also prepared with 500 mM
imidazole and 2 mM BME dissolved in PBS, vacuum filtered and pH=7.4.
Three SNAP-25-TS purifications were performed using this Ni-NTA
column, one for each buffering condition (5 mM, 10 mM, and 20 mM imidazole
in the equilibration buffer). The pellet of SNAP-25 TS containing cells was
resuspended in 10 ml of equilibration buffer and sonicated at 12 Watts using the
probe sonicator for five minutes. The solution was then centrifuged at 14,000 rpm
for 25 minutes at 4°C to remove the cell debris. The supernatant was subsequently
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passed through a 0.45 µm filter and was then added to the Ni-NTA column in 1
ml fractions. The column was then washed 15 times with equilibration buffer to
remove any proteins nonspecifically bound to the column. After the 15th wash
step, the elution buffer was added in 1 ml fractions, and each of these elution
fractions was collected in Eppendorf tubes. Ten elution fractions total were
collected for each purification.
After testing 5 mM, 10 mM, and 20 mM concentrations of imidazole in
the equilibration buffer, the 20 mM imidazole buffering condition was found to be
best at minimizing nonspecific binding, as revealed by SDS-PAGE. Figure 2.7
shows the 10% SDS-PAGE gels comparing the SNAP-25 T-Sapphire
purifications using varying concentrations of imidazole in the equilibration buffer.
The first elution fraction is shown for 5 mM, 10 mM, and 20 mM imidazole
purifications. As the concentration of imidazole increases, the number of protein
bands in the elution fraction decreases, which is indicative of fewer protein
contaminants.

	
  

Figure 2.7 10% SDS-PAGE gels comparing the various imidazole concentrations in
the equilibration buffer during purification on a 5 ml column packed with Ni-NTA
beads. The first panel shows a purification using 5 mM imidazole in the
equilibration buffer, the second panel is a purification with 10 mM imidazole, and
the third panel is a purification with 20 mM imidazole. The first elution fraction is
shown for each purification. The arrow points to the SNAP-25 T-Sapphire bind
(~64.2 kDa). As the concentration of imidazole in the equilibration buffer increases,
the number of protein bands in the elution fraction decreases, which indicates fewer
contaminants and a more pure sample.
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Purification on the FPLC
Once buffering conditions were optimized, the SNAP-25 T-Sapphire was
purified on the FPLC. The frozen cell pellet was thawed in a water bath at room
temperature. Using a glass rod, the cells were resuspended in 20 ml of
equilibration buffer (20 mM imidazole and 2 mM BME dissolved in PBS and
vacuum filtered, pH=7.4). One protease inhibitor tablet (Roche) was dissolved in
the solution before 10 rounds of sonication on the probe sonicator for 30-second
intervals at 12 Watts. Once the cells were sufficiently lysed, the solution was
centrifuged at 14,000 rpm for 30 minutes at 4°C. The cell debris was discarded,
and the supernatant was loaded into the HisTrap FF column (GE) on the FPLC. A
linear gradient of imidazole from 20 mM to 500 mM was flowed through the
column to elute off the protein, and fractions that corresponded to a high UV
signal were collected. These fractions were also viewed under UV light to
confirm fluorescence (Figure 2.8).
Purity was assessed by running a 10% SDS-PAGE protein gel (Figure
2.9). In an attempt to further concentrate and purify the protein, two rounds of
dialysis were performed in thiol buffer (20 mM citric acid, 35 mM Na2HPO4, 108
mM NaCl, and 1 mM EDTA, pH=6.5) at 4°C. This buffer was chosen because it
has been shown to stabilize vesicles, and citric acid, as an electron donor, is a
reducing agent. The slightly acidic pH of the buffer also helps to keep the protein
reduced and prevents crosslinking [22].
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Figure 2.8 Sample fractions taken from the FPLC
purification of SNAP-25 T-Sapphire and imaged
under UV light. The elution fraction on the left
contains the fluorescent protein and corresponds to a
high UV signal on the FPLC, while the fraction on the
right is not fluorescent and had a low UV signal on
the FPLC.

	
  

Figure 2.9 10% SDS-PAGE gel assessing the purity of SNAP-25 T-Sapphire after
purification on the FPLC. SNAP-25 T-Sapphire is 64.2 kDa. Elution fractions 1 and
2 were fluorescent and had a high UV signal on the FPLC. In the last lane of the gel,
8M urea was added to Elution Fraction 1 before running the gel to ensure that the
protein is not aggregating and is in its monomeric form.
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Discussion
Initial attempts at purifying SNAP-25 T-Sapphire provide promising
results. The emission peak at 511 nm seen 24 hours after induction (Figure 2.6)
indicates that the T-Sapphire protein is being expressed and is fluorescent.
Additionally, the fact that distinct elution fractions with a relatively high UV
signal were generated during the FPLC purification and that these fractions were
fluorescent (Figure 2.8) further illustrates that the purification worked correctly.
The 10% SDS-PAGE gel in Figure 2.9 confirms that the SNAP-25 T-Sapphire
protein is present and relatively pure, although a few faint bands can be seen
underneath the SNAP-25 TS band. Furthermore, the addition of 8M urea to the
purified SNAP-25 TS reveals that the protein is in its reduced (monomeric) form
and has not aggregated. At a concentration of 8M, urea is a strong denaturant, so
if the protein were dimerizing, it would have been revealed in the gel.
In an attempt to remove any remaining impurities from the SNAP-25 TS,
dialysis was performed after purification on the FPLC. Dialysis was performed as
previously described (Section 2.2.3). Unfortunately, in these preliminary
experiments, inefficiencies in the dialysis process led to the loss of protein, so the
remaining concentration was extremely low at 200 nM (measured on the
Nanodrop). Figure 2.10 shows a 10% SDS-PAGE gel of the SNAP-25 TS protein
after dialysis. As the protein is of relatively high purity before dialysis, in future
purifications, the dialysis can probably be omitted with no major consequences.
Despite the low concentration of the protein after dialysis, we were still able to
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demonstrate binding of the SNAP-25 T-Sapphire construct to lipid-coated
microspheres. These results are presented in Chapter 4.
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Figure 2.10 10% SDS-PAGE gel depicting the purified SNAP25 TS protein after two rounds of dialysis. The arrows point to
the protein band for SNAP-25 TS (64.2 kDa).
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Chapter Summary and Conclusions
Chapter 2 describes the construct design and purification of SNAP-25
GFP, as well as the brand new protein construct, SNAP-25 T-Sapphire. The TS
fluorophore is a GFP mutant and is more stable and has improved folding
compared to GFP, as well as a significantly larger Stokes Shift [20]. For these
reasons, efforts are underway to switch fluorescence-based SNAP-25 protease
assays to this new T-Sapphire chromophore. The T-Sapphire plasmid was
synthesized by GenScript, and a restriction digestion was performed to ensure
plasmid correctness. Fluorescence measurements after induction confirm that the
protein is being induced and expressed. Buffering conditions for the purification
were optimized, and SDS-PAGE reveals that we were able to purify the protein in
these initial FPLC protocols. However, impurities in the protein still exist, and
dialysis and filtration methods after purification must be optimized further.
Ultimately, however, both GFP and T-Sapphire SNAP-25 protein were
successfully obtained, allowing for the performance of the measurements
presented in the remainder of this thesis.

Chapter 3
ASSAY DESIGN AND ATTACHMENT OF SNAP-25 TO MICROSPHERES
3.1

Introduction
Supported lipid bilayers (SLBs) on microspheres are used for a variety of
biomedical applications due to their ability to mimic a biological membrane [23].
SLBs are composed of a phospholipid bilayer where the hydrophobic tail groups
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of the lipids are oriented inwards, and the hydrophilic head groups are oriented
outwards. While greatly oversimplified compared to a eukaryotic membrane,
SLBs still have many advantages in their ability to mimic a biological
environment [23]. First, due to the fact that a very thin (1-2 nm) layer of water sits
between the microsphere and the membrane, SLBs are able to maintain lateral
fluidity comparable to a biological membrane [23]. Figure 3.1 shows the structure
of a SLB on a silica microsphere. Additionally, these silica microspheres provide
a stable platform for the study of membrane proteins once they are inserted into
the bilayer [23]. Soluble proteins can be anchored to the lipid bilayer using a
variety of attachment strategies [23]. In the present context, we hypothesize that
the membrane plays a key role in facilitating the interactions between proteases
and membrane-bound substrates. Therefore, we hope to study these interactions in
the presence of a membrane in order to gain a more complete understanding of the
enzymatic processes involved in proteolytic cleavage, and for such studies, the
use of SLBs formed on microspheres is an excellent material platform.
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Figure 3.1 Illustration of a supported lipid bilayer formed around a silica microsphere. A thin, 2 nm layer of water
separates the microsphere from the phospholipid bilayer, thus mimicking the lateral mobility of a biological membrane.
Figure adapted from Chemburu, S. et al. (2010). [23]
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Attachment Strategy of SNAP-25 to Lipid-Coated Microspheres
In order to peripherally attach SNAP-25 to a membrane-coated
microsphere, we employed sulfhydryl-reactive crosslinking. Sulfhydryls (thiols)
are one of the most common crosslinkers used in bioconjugation techniques,
second only to primary amines [24]. We chose to use thiol crosslinking for several
reasons. First, due to the fact that sulfhydryls are present in most proteins but are
not as common as primary amines, the amount of crosslinking can be more
precisely controlled [24]. Second, because sulfhydryls in proteins generally form
disulfide bonds, crosslinking at these regions rarely blocks binding sites or alters
native protein structure [24].
The side chains of cysteine residues in SNAP-25 contain sulfhydryls
(--SH), and pairs of these sulfhydryl groups are generally linked by a disulfide
bond within the protein (--S-S--). When in the reduced form (--S), they are free to
bind with thiol-reactive compounds [24]. Maleimides specifically react with
sulfhydryls by forming a stable and irreversible thioether linkage when
conjugated between pH 6.5 and 7.5 (mechanism shown in Figure 3.2) [24]. Using
this attachment chemistry, we can reduce the SNAP-25 protein so that its
sulfhydryl groups are free to form a disulfide bridge with the maleimidecontaining lipid, 1,2-dihexadecanoyl-sn-glycero-3- phosphoethanolamine-N- [4(p-maleimidophenyl)butyramide]

(MPB-PE).

We

coat

nonporous

silica

microspheres with lipid bilayers that contain various concentrations of this MPBPE lipid, which can then form a disulfide bond with the sulfhydryls in the SNAP25 protein. This attachment strategy gives us the ability to study
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protease/substrate interactions in the presence of a lipid membrane. A schematic
of this sulfhydryl attachment is shown in Figure 3.3.
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Figure 3.2 Mechanism of protein conjugation with a maleimide group. Figure
taken from Bioconjugate Techniques, 3rd Ed. [24].

	
  

Figure 3.3 Attachment strategy of fluorescently-tagged SNAP-25 to a lipid-coated
microsphere. The SNAP-25 protein is shown in blue, with a fluorescent molecule
(green) attached at the C terminus. The maleimide-containing lipid MPB-PE is shown
in red and can form a disulfide bridge with the cysteine residues on the SNAP-25.
Figure adapted from José Cornejo’s thesis [30].
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3.3

Materials and Methods

3.3.1

Lipid Preparation
1 mM stock solutions were prepared of the following lipids in chloroform:
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine

(POPC)

and

1,2-

dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidophenyl)
butyramide] (MPB-PE). From these stock solutions, chloroform solutions with the
following mole percentages were prepared in glass vials, typically with a total
lipid concentration of 1 mM in 800 µl volume: 1) 100% POPC 2) 99% POPC and
1% MPB-PE 3) 95% POPC and 5% MPB-PE 4) 90% POPC and10% MPB-PE.
Figure 3.4 shows the structure of the two lipids used in this study and discusses
some of their key properties. The vials were left under vacuum overnight to
evaporate off the chloroform, and then the lipid film was rehydrated in thiol
buffer (20 mM citric acid, 35 mM Na2HPO4, 108 mM NaCl, and 1 mM EDTA,
pH=6.5) to a final lipid concentration of 1 mM (again, typically at 800 µl total
volume). After adding buffer, the samples were vortexed by hand until the lipids
were resuspended in solution. In order to create monodispersed liposomes, the
samples were passed through an Avanti extruder (0.1 µm membrane) at least 17
times (or, if necessary, until the solution turned from cloudy to clear). This
solution was then aliquoted into autoclaved Eppendorf tubes at a sample volume
of 250 µl each.

	
  

Figure 3.4 Structures and properties of the phospholipid POPC and maleimidecontaining lipid MPB-PE. Images taken from Avanti [31].
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Characterization of Microspheres using Flow Cytometry
Three micron, nonporous silica microspheres (Spherotech) were chosen
for this study for several reasons. First, these microspheres are roughly similar in
size to eukaryotic cells (~10 microns) or organelles (~1 micron), and in an effort
to make these particles biomimetic, we try to mimic structures of mammalian
cells as closely as possible. Second, the fact that these beads are nonporous is
advantageous because the absence of pores on the bead surface can help ensure a
more even lipid coating, and a bulk silica surface is generally better characterized
and understood than porous surfaces. Third, a large body of literature exists that
use supported lipid bilayers on silica microspheres [23,25,26], so we can draw
from this previous work.
In order to determine the optimal number density of beads to use, we
performed a series of serial dilutions from ~108 to ~104 beads/ml and counted the
particles on the Accuri flow cytometer. We found that the ability for the Accuri to
reliably count individual particles saturates at a particle concentration of
approximately 7×106 beads/ml (Figure 3.5). Based on this data, we determined
that a good choice for number density of beads to use is well below this saturation
point, or approximately 106 beads/ml.

	
  

Figure 3.5 Particle counting experiment on the Accuri flow cytometer using 3
micron nonporous silica beads. The blue line depicts expected events/second, which
were calculated by multiplying the flow rate (ml/min) by the concentration
(beads/ml), and converting to second. The red line depicts the actual number of
events/second.
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After determining the optimal number of beads to add to the lipids, we
wanted to ensure that we have enough lipids per sample to sufficiently coat this
volume of beads. In other words, the lipids must be in great excess of the beads.
The following estimate was performed:
Surface Area of a Sphere: A=4πr2
From the Spherotech data sheet, the mean silica bead diameter is 3.14 µm (r=1.57 µm)
A=4π (1.57 µm)2 = 30.97 µm2/ bead
Area of POPC Head Group= 70Å2 per lipid = 7*10-7 µm2/lipid
Determining Lipids per Bead:

µμ𝑚!
30.97 𝑏𝑒𝑎𝑑
7 ∗ 10!!

µμm!
𝑙𝑖𝑝𝑖𝑑

=

4.42 ∗ 10!   𝑙𝑖𝑝𝑖𝑑𝑠
          (𝐦𝐨𝐧𝐨𝐥𝐚𝐲𝐞𝐫)
𝑏𝑒𝑎𝑑

4.42 ∗ 10!   𝑙𝑖𝑝𝑖𝑑𝑠
8.85 ∗ 10!   𝑙𝑖𝑝𝑖𝑑𝑠
  ×2 =
        (𝐛𝐢𝐥𝐚𝐲𝐞𝐫)
𝑏𝑒𝑎𝑑
𝑏𝑒𝑎𝑑
Determining Number of Lipids per mL:
8.85 ∗ 107 𝑙𝑖𝑝𝑖𝑑𝑠
  𝑏𝑒𝑎𝑑

  ×   

106 𝑏𝑒𝑎𝑑𝑠
𝑚𝐿

   =

8.85 ∗ 1013 𝑙𝑖𝑝𝑖𝑑𝑠
𝑚𝐿

Determining Number of Lipids Required to Coat Beads in a 250 µl Sample of 1 mM Lipid
Solution:
8.85 ∗ 10!"     lipids                

𝑚𝐿

   ∗   0.250  mL   = 2.21 ∗ 1013   𝑙𝑖𝑝𝑖𝑑𝑠

Determining Total Number of 1 mM Lipids in 250 µl Sample:

0.001  𝑚𝑜𝑙 6.02 ∗ 10!"   𝑙𝑖𝑝𝑖𝑑  𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
   ∗   
∗   0.00025  𝐿 =     1.51 ∗ 10!" 𝑙𝑖𝑝𝑖𝑑𝑠
𝐿
𝑚𝑜𝑙
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Determining Lipid Excess:

1.51 ∗ 10!"   𝑙𝑖𝑝𝑖𝑑𝑠  𝑖𝑛  𝑠𝑎𝑚𝑝𝑙𝑒
= 6.83 ∗ 10!     𝑙𝑖𝑝𝑖𝑑  𝑒𝑥𝑐𝑒𝑠𝑠
2.21 ∗ 10!"   𝑙𝑖𝑝𝑖𝑑𝑠  𝑟𝑒𝑞𝑢𝑖𝑟𝑒𝑑
This calculation shows that the available lipids are in approximately
7,000-fold excess of the lipids required for full bead coverage.

3.3.3

Formation of Lipid Bilayers around Microspheres
After determining the optimal number of beads to add to the lipid solution,
we can form supported lipid bilayers (SLBs) around the microspheres. Beads
were added to each of the following samples at a concentration of 106
particles/ml: 100% POPC + 0% MPB-PE, 99% POPC + 1% MPB-PE, 95%
POPC + 5% MPB-PE, and 90% POPC + 10% MPB-PE. The samples were then
placed in a vortex carousel (VWR) on high at room temperature for ten minutes,
and then vortexed on low speed for 45 minutes at 37°C. The SLBs form
spontaneously around the microspheres. In order to confirm that the beads are
adequately coated with lipids, 0.5 molar percent of a headgroup-labeled
carboxyfluorescein

lipid,

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-

carboxyfluorescein (CF-PE), was integrated into the membrane for imaging on a
confocal microscope (Zeiss) and subsequent analysis on the Accuri flow
cytometer. In confocal microscopy, Z-stack slices were taken in 1 micron slices
through the microspheres to further verify the presence of an even and complete
lipid coating. Figure 3.6 shows confocal images of lipid-coated beads at various
maleimide lipid concentrations as well as the median fluorescence values and

	
  

50

flow cytometry data from the corresponding samples, as measured on the Accuri
C6.
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Figure 3.6 Analysis of lipid coating on silica
microspheres. A) Confocal images taken of
samples with 0%, 1%, 5%, and 10% MPB-PE. The
remainder of the bilayer is composed of POPC and
0.5% CF-PE. Images were taken on the Zeiss
confocal microscope with a 63X oil immersion
lens. B) Flow cytometric data corresponding to the
samples imaged on the confocal. Measurements
were taken on the Accuri C6 flow cytometer. C)
Median fluorescence values corresponding to the
histograms in B.
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Bovine Serum Albumin (BSA) Blocking
A BSA block was incorporated into the protocol for several reasons. First,
as mentioned previously, impurities in the SNAP-25 GFP can lead to nonspecific
binding of protein contaminants to the lipid membrane. Second, BSA can block
portions of the silica surface that are exposed due to defects in the membrane. It
has been shown in the literature that 100 µg/ml of BSA is the optimal
concentration for preventing nonspecific binding on SLBs because nonspecific
interactions are sufficiently blocked at this concentration while still maintaining
the lateral mobility and structural integrity of the membrane [27]. Blocking with
higher concentrations of BSA can lead to holes in the bilayer where the BSA has
displaced portions of the membrane, and lower concentrations do not adequately
prevent nonspecific binding [27]. Based on these results, 100 µg/ml of BSA were
added to each sample and allowed to incubate on the shaker at low speed at room
temperature for 45 minutes. In order to remove any unbound BSA in solution,
three wash steps were performed by centrifuging the samples at 10,000 rpm for 45
seconds, removing the supernatant (being careful to leave the bead pellet
hydrated), and resuspending the beads in fresh buffer. After the last wash step, the
beads were resuspended in 100 µl of buffer instead of 250 µl in order to leave
room for the addition of SNAP-25 GFP. After the BSA blocking and wash steps
are completed, the SNAP-25 protein can be conjugated to the maleimide lipids in
the membrane. Figure 3.7 compares SNAP-25 GFP binding in samples that were
blocked with BSA versus no blocking. The x-axis represents fluorescence
intensity, while the y-axis shows event count. The red lines depicts samples where
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no SNAP-25 GFP was added, the blue lines are samples with 200 nM SNAP-25
GFP, and the orange lines are samples with 500 nM SNAP-25 GFP. Both data
sets shown in this figure were prepared using 100% POPC for the lipid coating
and do not contain any MPB-PE. Because there are no maleimide-containing
lipids for the SNAP-25 GFP to bind to, the fluorescence intensity should not
depend on SNAP-25 GFP concentration. In the graph on the left with no BSA
blocking, however, the fluorescence intensity increases as the concentration of
SNAP-25 GFP increases, indicating that the protein is nonspecifically binding to
the microsphere. In contrast, in the graph on the right where a BSA block was
performed, the fluorescence intensity does not change with increasing
concentrations of SNAP-25 GFP, indicating that the BSA is effectively blocking
the protein from nonspecifically binding to the microsphere.

	
  

Figure 3.7 Comparison of SNAP-25 GFP conjugation to lipid-coated microspheres
with and without BSA blocking. The membranes coating these microspheres
contain no MPB-PE and are 100% POPC. The red line depicts samples with no
SNAP-25 GFP added, the blue line depicts samples with 200 nM SNAP-25 GFP,
and the orange line are samples with 500 nM of SNAP-25 GFP.
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Conjugation of SNAP-25 to MPB-PE
Because the reducing agent DTT was incorporated into the equilibration
and elution buffers during purification, the SNAP-25 GFP should already be in its
reduced form. This is confirmed using SDS-PAGE by the absence of a protein
dimer band (Figure 2.3). Residual DTT was removed from the sample by
centrifugation with a MWCO filter and dialysis (described previously in Chapter
2). Buffer and then SNAP-25 GFP (at concentrations of 0 nM, 200 nM, and 500
nM) were added to samples to bring the sample volume back up to 250 µl. To
prevent oxidation of the protein, all samples were passed under an argon stream
for 30 seconds. They were then placed on a rotator overnight at 4°C to allow time
for the SNAP-25 GFP to bind to the MPB-PE. Results that confirm SNAP-25
GFP binding to lipid-coated microspheres are shown in Figure 3.8. In this figure,
fluorescence intensity is shown on the x-axis and event count is shown on the yaxis. In the histogram to the left, the membrane contains 100% POPC and no
maleimide-containing lipid MPB-PE. 0 nM of SNAP-25 GFP is shown in red,
200 nM is in blue, and 500 nM is in orange. The fact that the peaks strongly
overlap indicates that there is little nonspecific binding occurring. In the graph on
the right, the following concentrations of SNAP-25 were added to microspheres
coated with a membrane containing 10% MPB-PE + 90% POPC lipids: 0 nM
SNAP-25 GFP in red, 200 nM in blue, and 500 nM in orange. We would expect
the fluorescence intensity to increase as the concentration of fluorescent protein
increases, and this trend is clearly visible.

	
  

Figure 3.8 Analysis of SNAP-25 GFP binding to lipid-coated microspheres. The
graph on the left is 100% POPC and contains no maleimide lipid, and the graph on
the right contains 10% MPB-PE + 90% POPC. The red line represents samples with
0 nM SNAP-25 GFP, the blue line is 200 nM SNAP-25 GFP, and the orange line is
500 nM SNAP-25 GFP.

56

	
  

3.3.6

57

Incubation with Protease
After confirmation that the SNAP-25 GFP is sufficiently binding the lipid
membrane, proteases were introduced to the samples. All samples were split into
thirds (one control set where no protease was added, one set where trypsin was
added, and one set where BoNT/A was added). Figure 3.9 outlines the sample
preparation and analysis for this portion of the study.
Trypsin is a protease that catalyzes the hydrolysis of peptide bonds at the
C-terminal side of lysine and arginine amino acids [28]. Because virtually all
proteins contain these residues, trypsin is often used as a general protease [28].
We employ trypsin as a positive control to show that proteolytic cleavage of
SNAP-25 GFP is occurring. BoNT/A, on the other hand, has an extremely high
specificity for SNAP-25, so proteolytic cleavage of SNAP-25 by BoNT/A will not
only allow for detection of the toxin, but will also provide important information
regarding the enzymatic activity of the toxin’s interaction with its membranebound substrate. After the proteases are added, the samples are placed on a rotator
at 37°C to incubate.

	
  

Figure 3.9 Schematic depicting the steps of sample preparation and analysis of
SNAP-25 GFP conjugation to membrane-coated microspheres and subsequent
proteolytic cleavage.
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Flow Cytometric Analysis
Initial measurements are taken on the Accuri C6 flow cytometer after the
overnight conjugation of SNAP-25 GFP to the lipid-coated microspheres. The
samples are measured again immediately after addition of the protease, and then
every hour after addition for two hours. This allows us to correlate protease
activity with time. The results of these protease cleavage assays are shown in
Section 3.4.

3.4

Results
Three replicates of the Trypsin/BoNT protease assay were preformed. The
samples that exhibited the best binding of the SNAP-25 GFP to the lipid
membrane were samples with 10% MPB-PE and 500 nM of protein, so the data
analysis presented in the remainder of this section reflects samples prepared under
these conditions. A discussion of how to improve upon the current protein
conjugation protocol can be found under Future Directions (Section 4.2).
Figure 3.10 exhibits the results of the three individual Trypsin/BoNT
protease assays. The x-axis shows the control, trypsin, and BoNT/A samples for
each of the three replicates, and the y-axis represents median fluorescence
intensity, as measured on the Accuri C6 flow cytometer. The blue lines are the
samples before the addition of the protease, the red lines are measurements taken
shortly after the protease was added (approximately 10 minutes), the green lines
are 1 hour after protease addition, and the purple lines are after 2 hours incubation
with the protease. The median fluorescence values were then averaged and
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plotted, and the standard deviation was used to make error bars. This data is
shown in Figure 3.11. Next, the averages of the three replicates for 10% MPB-PE,
500 nM SNAP-25 GFP were plotted, and the median fluorescence was
normalized to the control samples (no protease added) at each time point. These
results can be seen in Figure 3.12. In this graph, the x-axis represents time
(hours), where t=0 is just before addition of the protease. The y-axis is the ratio of
the median fluorescence to that of the control sample at each time point. Trypsin
is seen in blue, and BoNT/A is seen in red. Finally, a histogram that shows the
loss of fluorescence over time after incubation with the BoNT/A toxin for a single
replicate is also presented in Figure 3.13.

	
  

Figure 3.10 Results of three separate experiments after incubation with the
Trypsin of BoNT/A LC proteases. Median fluorescence is seen on the y-axis, and
the sample is on the x-axis. The blue line represents samples before the protease
was added, the red line is immediately after protease addition, the green line is
after a 1 hour incubation with the protease, and the purple line is after 2 hours
incubation.
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Figure 3.11 Results showing the average values of the three protease assay
replicates. The error bars were plotted using the standard deviation. The x-axis
represents the time points after addition of the protease for each sample, and the
median fluorescence values are plotted on the y-axis. Time points before the
protease was added are in blue, immediately after addition are in red, 1 hour after
addition are in green, and two hours are in purple.
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Figure 3.12 Graph depicting the activity of the BoNT/A LC and Trypsin proteases
over time on samples with 10% MPB-PE lipid and 500 nM SNAP-25 GFP. Trypsin is
seen in blue, and BoNT/A LC is red. The x-axis depicts time in hours. Time zero is
before the protease was added, and time points were taken at 0.15, 1, and 2 hours
after the protease was added. All median fluorescence values were normalized to the
control samples (no protease added) at each time point, and the error bars were
calculated using the standard deviation of these normalized fluorescence values.
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Figure 3.13 Histogram depicting flow cytometric data of 10% MPBPE, 500 nM SNAP-25 GFP samples incubated with BoNT/A LC.
Fluorescence intensity is on the x-axis, and count is on the y-axis. The
red line depicts the samples before addition of the protease, the orange
line is immediately after BoNT/A LC, the blue line is 1 hour after the
protease was added, and the green line is 2 hours after addition. Loss of
fluorescence can be observed over time.
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Discussion
The raw data of the three protease assay replicates plotted in Figure 3.10
clearly reveals a loss of fluorescence after incubation with the protease. The
trypsin, as a positive control, works extremely quickly and takes the fluorescence
to baseline within 10 minutes. The fluorescence decrease after adding the
BoNT/A is slower, as expected, but the reaction seems to run to completion in all
three cases after the two hour incubation period. While these results satisfy the
overall objective of this project, it is clear that the process still needs to be
optimized. In the first replicate, for example, the fluorescence of the trypsin and
BoNT/A samples before addition of the protease are extremely high. Because no
protease has been added at this point, the fluorescence values should be
comparable to the control. There may have been some variation in the sample
preparation. The third replicate exhibits the greatest amount of consistency of the
fluorescence in both the control samples over time, and the control samples before
addition of the protease.
In Figure 3.11, the same desired trend can be observed where the
fluorescence intensity decreases over time after addition of the protease, with
trypsin samples decreasing extremely quickly, and the BoNT/A samples running
to completion after approximately 2 hours. Additionally, the error bars presented
in this plot (by averaging all three replicates and calculating the standard
deviation) probably over-estimate the error because while there is a great deal of
variation between replicates, the numbers are much tighter within each individual
experiment. The variation in fluorescence between replicates may be due to day-
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to-day variations in the Accuri C6 instrument, as well as variation in the sample
preparation.
In Figure 3.12, all data was normalized to the control samples (no protease
added) at each time point. While the greatest amount of error lies in the first time
point (before the protease was added), the desired trend can still be seen where the
trypsin causes loss of fluorescence very quickly, and the BoNT/A takes
approximately two hours to run to completion.
Figure 3.13 demonstrates the loss of fluorescence after incubation with
BoNT/A for a single sample (10% MPB-PE, 500 nM SNAP-25 GFP) over time.
While the secondary peak is clearly visible in the control sample before the
protease was added, the assay overall is achieving the desired effect.

3.6

Chapter Summary and Conclusions
In this chapter, we demonstrated specific binding of SNAP-25 GFP to a
membrane-coated microsphere via attachment to the maleimide-containing lipid
MPB-PE. BSA blocking procedures were optimized, and stability of the lipid
coating surrounding these microspheres was assessed. We successfully
demonstrated cleavage of the SNAP-25 GFP protein by both the trypsin and
BoNT/A proteases and were able to quantify the enzymatic activity of these
proteases on the protein substrate over time. While the need to optimize the
protein binding and lipid preparation protocols still exist, we achieved the overall
goal of this project to develop a flow-based assay for the study of proteases on
membrane-associated substrates in the presence of a lipid bilayer.
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Chapter 4
SUMMARY AND FUTURE DIRECTIONS

4.1

Summary of Work
Poisoning by botulinum neurotoxins leads to the severe illness Botulism,
which is characterized by flaccid paralysis, respiratory failure, and death. Due to
the extreme toxicity of BoNTs, detection of the toxin is difficult, and current
clinical diagnostic techniques take approximately 2-3 days to perform [1].
Furthermore, studies disagree on the mechanistic interpretations regarding the
action of the toxin on its SNARE protein substrates [29]. In an effort to better
understand the interaction between BoNTs and SNARE proteins in a
psychologically relevant environment, we have developed a flow-based assay
platform that allows for the study of BoNT activity in the presence of a
membrane. The total assay time has been reduced to approximately 20 hours, and
we can readily detect BoNTs in the nM range, which is comparable to many
current techniques.
We have successfully purified two constructs of the SNAP-25 protein:
SNAP-25 GFP and SNAP-25 T-Sapphire. We have demonstrated binding of the
SNAP-25 GFP protein to the maleimide-containing lipid MPB-PE, thus anchoring
the protein to a membrane-coated microsphere, enabling flow-based assays. We
have also demonstrated that we can detect the presence of BoNT/A LC via flow
cytometry by observing a loss of fluorescence after incubation with the protease.
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Again, due to the presence of a lipid bilayer, this system allows us to study how
BoNTs act on membrane-bound proteins in a biological environment.

4.2

Future Directions
As described in Section 2.1, the T-Sapphire fluorophore has improved
folding, is more stable under physiological conditions, and has a larger Stokes
shift compared to GFP. In an effort to utilize these advantages, we must continue
to optimize the expression and purification of the full-length SNAP-25 TSapphire construct. This effort is important in order to create a more robust
system for the study of protease interactions with membrane-bound substrates.
Figure 4.1 presents preliminary data showing the binding of purified SNAP-25 TSapphire to a lipid-coated microsphere containing 10% MPB-PE. This assay was
prepared using the procedures described in Chapter 3 (the process is outlined in
Figure 3.9). Measurements were taken on the LSR Fortessa flow cytometer with a
405 nm excitation wavelength. In this figure, the x-axis represents fluorescence
intensity on a 525/50 nm channel, and the y-axis is event count. The sample with
0 nM SNAP-25 TS is seen in red, 50 nM SNAP-25 TS is in blue, and 100 nM is
in orange. While there is not a great difference in binding between the 50 nM and
100 nM protein samples, there is a clear increase in fluorescence compared to the
baseline (0 nM SNAP-25 TS) sample, indicating that the protein is binding to the
maleimide-containing lipid MPB-PE in the membrane. While this preliminary
data is encouraging, the SNAP-25 T-Sapphire purification and conjugation to
lipid-coated microspheres must continue to be optimized.
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Figure 4.1 Preliminary data demonstrating the binding of
SNAP-25 T-Sapphire to microspheres coated with 10%
MPB-PE + 90% POPC lipids. The red line are samples with
0 nM SNAP-25 TS, the blue line is 50 nM SNAP-25 TS, and
the orange line is 100 nM.
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In addition to optimizing the SNAP-25 T-Sapphire purification, the assay
protocol must also be optimized in order to decrease nonspecific binding and
increase stability of the lipid-coated microspheres. In many of the samples, a
second fluorescent peak is visible after gating around the bead population in the
flow cytometry data, and this second peak cannot be gated out of the sample.
Figure 4.2 shows an example of data with this secondary peak. Though the exact
cause of this issue remains to be seen, it can potentially be attributed to a number
of factors. First, it is possible that this secondary fluorescent peak is caused by
protein nonspecifically binding to the membrane. Because the SNAP-25 GFP
construct is biotinylated and biotin is hydrophobic, the biotin could also be
nonspecifically interacting with the membrane. Moving towards the SNAP-25 TSapphire protein construct (which is not biotinylated) will help to decrease the
likeliness of the protein nonspecifically interacting with the membrane. Second, it
is also possible that the SNAP-25 protein is crosslinking and the second peak is
due to aggregation. In this case, it is necessary to optimize the protein reduction
during purification and subsequent conjugation to the lipid-coated microspheres
under reduction conditions. Third, it is also possible that degradation of the lipid
membrane is occurring. In order to check on this, we must incorporate a
fluorescently-labeled lipid control into the protocol. We can measure the
fluorescence of these lipid-coated beads at each time point in the protocol to
ensure that the membrane is remaining stable throughout the entire assay.
Despite this second peak, however, the fluorescence intensity still clearly
decreases with addition of the protease, indicating that the assay is working.
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Figure 4.2 Sample containing 5% MPB-PE and 95%
POPC in the lipid membrane and incubated with 200
nM of SNAP-25 GFP. Fluorescence intensity is on the
x-axis, and count is on the y-axis.
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The study of toxin action on membrane-bound substrates in a
physiologically relevant environment has many important broader impacts, and
the eventual goal of this work is to explore these possibilities. First, due to the
extremely fast analysis time of flow-based assay platforms, this assay design is
capable of high throughput screening for drug discovery. Secondly, because the
current antitoxin treatment for botulism is membrane impermeable and therefore
cannot reverse existing paralysis, drug discovery is key for developing more
effective treatments. The presence of a membrane in our assay more accurately
models a biological system, which is an important factor for drug screening and
can lead to more effective treatments. Third, this flow-based assay has
multiplexing capability, which allows for cross-reactivity studies. Again, the
presence of a membrane may be an important factor in studying the enzymatic
activity of the toxin on its membrane-bound substrates. Finally, the membranebased platform we developed can potentially be used to study other toxins and
their activity in a more physiologically relevant environment than that previously
employed in microsphere-based assays.
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Appendix
FULL-LENGTH CONSTRUCTS OF SNAP-25 GFP AND SNAP-25 T-SAPPHIRE
Full-Length Biotinylated SNAP-25 GFP Plasmid in the Pinpoint Xa-1 Vector
ATGAAACTGAAGGTAACAGTCAACGGCACTGCGTATGACGTTGACGTTGACGTCGACAAGTCACACGAAAACCCGATGGGCACCA
TCCTGTTCGGCGGCGGCACCGGCGGCGCGCCGGCACCGGCAGCAGGTGGCGCAGGCGCCGGTAAGGCCGGAGAGGGCGAGATTCC
CGCTCCGCTGGCCGGCACCGTCTCCAAGATCCTCGTGAAGGAGGGTGACACGGTCAAGGCTGGTCAGACCGTGCTCGTTCTCGAG
GCCATGAAGATGGAGACCGAGATCAACGCTCCCACCGACGGCAAGGTCGAGAAGGTCCTGGTCAAGGAGCGTGACGCGGTGCAGG
GCGGTCAGGGTCTCATCAAGATCGGGGATCTCGAGCTCATGGCCGAAGACGCAGACATGCGCAATGAGCTGGAGGAGATGCAGCG
AAGGGCTGACCAGTTGGCTGATGAGTCGCTGGAAAGCACCCGTCGTATGCTGCAACTGGTTGAAGAGAGTAAAGATGCTGGTATC
AGGACTTTGGTTATGTTGGATGAACAAGGAGAACAACTCGATCGTGTCGAAGAAGGCATGAACCATATCAACCAAGACATGAAGG
AGGCTGAGAAAAATTTAAAAGATTTAGGGAAATGCTGTGGCCTTTTCATATGTCCTTGTAACAAGCTTAAATCAAGTGATGCTTA
CAAAAAAGCCTGGGGCAATAATCAGGACGGAGTGGTGGCCAGCCAGCCTGCTCGTGTAGTGGACGAACGGGAGCAGATGGCCATC
AGTGGCGGCTTCATCCGCAGGGTAACAAATGATGCCCGAGAAAATGAAATGGATGAAAACCTAGAGCAGGTGAGCGGCATCATCG
GGAACCTCCGTCACATGGCCCTGGATATGGGCAATGAGATCGATACACAGAATCGCCAGATCGACAGGATCATGGAGAAGGCTGA
TTCCAACAAAACCAGAATTGATGAGGCCAACCAACGTGCAACAAAGATGCTGGGAAGTGGGCGGATCCACCGGCCGGTCGCCACC
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCA
GCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCC
CTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTC
AAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGA
AGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCT
GGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCAC
AACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACA
ACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGC
CGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAAAGCGGCCGCGATCTGGTTCTATAGTGTCACCTAAATCGTATGTGT
ATGATACATAAGGTTATGTATTAATTGTAGCCGCGTTCTAACGACAATATGTCCATATGGTGCACTCTCAGTACAATCTGCTCTG
ATGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTA
CAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGACGAAAGGGCCTC
GTGATACGCCTATTTTTATAGGTTAATGTCATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCG
GAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATA
TTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCT
CACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCG
GTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATC
CCGTATTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAA
AAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTC
TGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACC
GGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTTGCGCAAACTATTAACT
GGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGG
CCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGA
TGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATA
GGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAAT
TTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGA
CCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTA
CCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATA
CTGTTCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTT
ACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCG
GGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAG
AAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCT
TCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCA
GGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCT
TTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGA
GCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGC
AGGTTAACCTGGCTTATCGAAATTAATACGACTCACTATAGGGAGACCGGCCTCGAGCAGCAAGGAGATGGCGCCCAACAGTCCC
CCGGCCACGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGA
TGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCGTCCGGCGTAGAGGATCGATCCGGG
CTTATCGACTGCACGGTGCACCAATGCTTCTGGCGTCAGGCAGCCATCGGAAGCTGTGGTATGGCTGTGCAGGTCGTAAATCACT
GCATAATTCGTGTCGCTCAAGGCGCACTCCCGTTCTGGATAATGTTTTTTGCGCCGACATCATAACGGTTCTGGCAAATATTCTG
AAATGAGCTGTTGACAATTAATCATCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGAATTC
CCAGCTTGGCTGCAGAACCATTCCATTCGTTGATCCGGGAGTAACTCAC
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Full-Length SNAP-25 T-Sapphire Plasmid in the pET-15b Vector
ttcttgaagacgaaagggcctcgtgatacgcctatttttataggttaatgtcatgataataatggtttcttagacgtcaggtggcact
tttcggggaaatgtgcgcggaacccctatttgtttatttttctaaatacattcaaatatgtatccgctcatgagacaataaccctgat
aaatgcttcaataatattgaaaaaggaagagtatgagtattcaacatttccgtgtcgcccttattcccttttttgcggcattttgcct
tcctgtttttgctcacccagaaacgctggtgaaagtaaaagatgctgaagatcagttgggtgcacgagtgggttacatcgaactggat
ctcaacagcggtaagatccttgagagttttcgccccgaagaacgttttccaatgatgagcacttttaaagttctgctatgtggcgcgg
tattatcccgtgttgacgccgggcaagagcaactcggtcgccgcatacactattctcagaatgacttggttgagtactcaccagtcac
agaaaagcatcttacggatggcatgacagtaagagaattatgcagtgctgccataaccatgagtgataacactgcggccaacttactt
ctgacaacgatcggaggaccgaaggagctaaccgcttttttgcacaacatgggggatcatgtaactcgccttgatcgttgggaaccgg
agctgaatgaagccataccaaacgacgagcgtgacaccacgatgcctgcagcaatggcaacaacgttgcgcaaactattaactggcga
actacttactctagcttcccggcaacaattaatagactggatggaggcggataaagttgcaggaccacttctgcgctcggcccttccg
gctggctggtttattgctgataaatctggagccggtgagcgtgggtctcgcggtatcattgcagcactggggccagatggtaagccct
cccgtatcgtagttatctacacgacggggagtcaggcaactatggatgaacgaaatagacagatcgctgagataggtgcctcactgat
taagcattggtaactgtcagaccaagtttactcatatatactttagattgatttaaaacttcatttttaatttaaaaggatctaggtg
aagatcctttttgataatctcatgaccaaaatcccttaacgtgagttttcgttccactgagcgtcagaccccgtagaaaagatcaaag
gatcttcttgagatcctttttttctgcgcgtaatctgctgcttgcaaacaaaaaaaccaccgctaccagcggtggtttgtttgccgga
tcaagagctaccaactctttttccgaaggtaactggcttcagcagagcgcagataccaaatactgtccttctagtgtagccgtagtta
ggccaccacttcaagaactctgtagcaccgcctacatacctcgctctgctaatcctgttaccagtggctgctgccagtggcgataagt
cgtgtcttaccgggttggactcaagacgatagttaccggataaggcgcagcggtcgggctgaacggggggttcgtgcacacagcccag
cttggagcgaacgacctacaccgaactgagatacctacagcgtgagctatgagaaagcgccacgcttcccgaagggagaaaggcggac
aggtatccggtaagcggcagggtcggaacaggagagcgcacgagggagcttccagggggaaacgcctggtatctttatagtcctgtcg
ggtttcgccacctctgacttgagcgtcgatttttgtgatgctcgtcaggggggcggagcctatggaaaaacgccagcaacgcggcctt
tttacggttcctggccttttgctggccttttgctcacatgttctttcctgcgttatcccctgattctgtggataaccgtattaccgcc
tttgagtgagctgataccgctcgccgcagccgaacgaccgagcgcagcgagtcagtgagcgaggaagcggaagagcgcctgatgcggt
attttctccttacgcatctgtgcggtatttcacaccgcatatatggtgcactctcagtacaatctgctctgatgccgcatagttaagc
cagtatacactccgctatcgctacgtgactgggtcatggctgcgccccgacacccgccaacacccgctgacgcgccctgacgggcttg
tctgctcccggcatccgcttacagacaagctgtgaccgtctccgggagctgcatgtgtcagaggttttcaccgtcatcaccgaaacgc
gcgaggcagctgcggtaaagctcatcagcgtggtcgtgaagcgattcacagatgtctgcctgttcatccgcgtccagctcgttgagtt
tctccagaagcgttaatgtctggcttctgataaagcgggccatgttaagggcggttttttcctgtttggtcactgatgcctccgtgta
agggggatttctgttcatgggggtaatgataccgatgaaacgagagaggatgctcacgatacgggttactgatgatgaacatgcccgg
ttactggaacgttgtgagggtaaacaactggcggtatggatgcggcgggaccagagaaaaatcactcagggtcaatgccagcgcttcg
ttaatacagatgtaggtgttccacagggtagccagcagcatcctgcgatgcagatccggaacataatggtgcagggcgctgacttccg
cgtttccagactttacgaaacacggaaaccgaagaccattcatgttgttgctcaggtcgcagacgttttgcagcagcagtcgcttcac
gttcgctcgcgtatcggtgattcattctgctaaccagtaaggcaaccccgccagcctagccgggtcctcaacgacaggagcacgatca
tgcgcacccgtggccaggacccaacgctgcccgagatgcgccgcgtgcggctgctggagatggcggacgcgatggatatgttctgcca
agggttggtttgcgcattcacagttctccgcaagaattgattggctccaattcttggagtggtgaatccgttagcgaggtgccgccgg
cttccattcaggtcgaggtggcccggctccatgcaccgcgacgcaacgcggggaggcagacaaggtatagggcggcgcctacaatcca
tgccaacccgttccatgtgctcgccgaggcggcataaatcgccgtgacgatcagcggtccagtgatcgaagttaggctggtaagagcc
gcgagcgatccttgaagctgtccctgatggtcgtcatctacctgcctggacagcatggcctgcaacgcgggcatcccgatgccgccgg
aagcgagaagaatcataatggggaaggccatccagcctcgcgtcgcgaacgccagcaagacgtagcccagcgcgtcggccgccatgcc
ggcgataatggcctgcttctcgccgaaacgtttggtggcgggaccagtgacgaaggcttgagcgagggcgtgcaagattccgaatacc
gcaagcgacaggccgatcatcgtcgcgctccagcgaaagcggtcctcgccgaaaatgacccagagcgctgccggcacctgtcctacga
gttgcatgataaagaagacagtcataagtgcggcgacgatagtcatgccccgcgcccaccggaaggagctgactgggttgaaggctct
caagggcatcggtcgagatcccggtgcctaatgagtgagctaacttacattaattgcgttgcgctcactgcccgctttccagtcggga
aacctgtcgtgccagctgcattaatgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgccagggtggtttttcttttc
accagtgagacgggcaacagctgattgcccttcaccgcctggccctgagagagttgcagcaagcggtccacgctggtttgccccagca
ggcgaaaatcctgtttgatggtggttaacggcgggatataacatgagctgtcttcggtatcgtcgtatcccactaccgagatatccgc
accaacgcgcagcccggactcggtaatggcgcgcattgcgcccagcgccatctgatcgttggcaaccagcatcgcagtgggaacgatg
ccctcattcagcatttgcatggtttgttgaaaaccggacatggcactccagtcgccttcccgttccgctatcggctgaatttgattgc
gagtgagatatttatgccagccagccagacgcagacgcgccgagacagaacttaatgggcccgctaacagcgcgatttgctggtgacc
caatgcgaccagatgctccacgcccagtcgcgtaccgtcttcatgggagaaaataatactgttgatgggtgtctggtcagagacatca
agaaataacgccggaacattagtgcaggcagcttccacagcaatggcatcctggtcatccagcggatagttaatgatcagcccactga
cgcgttgcgcgagaagattgtgcaccgccgctttacaggcttcgacgccgcttcgttctaccatcgacaccaccacgctggcacccag
ttgatcggcgcgagatttaatcgccgcgacaatttgcgacggcgcgtgcagggccagactggaggtggcaacgccaatcagcaacgac
tgtttgcccgccagttgttgtgccacgcggttgggaatgtaattcagctccgccatcgccgcttccactttttcccgcgttttcgcag
aaacgtggctggcctggttcaccacgcgggaaacggtctgataagagacaccggcatactctgcgacatcgtataacgttactggttt
cacattcaccaccctgaattgactctcttccgggcgctatcatgccataccgcgaaaggttttgcgccattcgatggtgtccgggatc
tcgacgctctcccttatgcgactcctgcattaggaagcagcccagtagtaggttgaggccgttgagcaccgccgccgcaaggaatggt
gcatgcaaggagatggcgcccaacagtcccccggccacggggcctgccaccatacccacgccgaaacaagcgctcatgagcccgaagt
ggcgagcccgatcttccccatcggtgatgtcggcgatataggcgccagcaaccgcacctgtggcgccggtgatgccggccacgatgcg
tccggcgtagaggatcgagatctcgatcccgcgaaattaatacgactcactataggggaattgtgagcggataacaattcccctctag
aaataattttgtttaactttaagaaggagatataccatgggcagcagccatcatcatcatcatcacagcagcggcctggtgccgcgcg
gcagccat...

	
  
...ATGAAACTGAAAGTGACGGTGAACGGCACGGCATACGATGTTGATGTCGATGTTGATAAAAGCCACGAAAAT
CCGATGGGCACGATCCTGTTTGGCGGTGGCACCGGTGGCGCACCGGCTCCGGCGGCCGGTGGCGCGGGTGCCGGC
AAAGCCGGTGAAGGCGAAATTCCGGCACCGCTGGCTGGCACGGTCAGCAAAATCCTGGTGAAAGAAGGCGATACC
GTGAAAGCCGGTCAGACGGTGCTGGTTCTGGAAGCTATGAAAATGGAAACCGAAATTAACGCGCCGACGGATGGC
AAAGTTGAAAAAGTCCTGGTGAAAGAACGTGATGCCGTCCAGGGTGGCCAAGGTCTGATTAAAATCGGTGATCTG
GAACTGATCGAAGGTCGTATGGCGGAAGATGCCGACATGCGCAATGAACTGGAAGAAATGCAGCGTCGCGCAGAT
CAACTGGCTGACGAATCACTGGAATCGACCCGTCGCATGCTGCAACTGGTGGAAGAAAGTAAAGATGCAGGTATT
CGCACGCTGGTTATGCTGGATGAACAGGGCGAACAACTGGACCGTGTCGAAGAAGGTATGAACCATATTAATCAG
GACATGAAAGAAGCGGAGAAAAACCTGAAAGACCTGGGCAAATGCTGTGGTCTGTTCATCTGCCCGTGTAATAAA
CTGAAAAGCTCTGACGCGTATAAGAAAGCGTGGGGCAACAATCAGGATGGTGTGGTTGCATCGCAACCGGCTCGT
GTCGTGGATGAACGCGAACAGATGGCTATTAGCGGTGGCTTTATCCGTCGCGTTACCAACGATGCGCGCGAAAAT
GAAATGGACGAAAACCTGGAACAGGTGTCCGGCATTATCGGTAACCTGCGTCACATGGCTCTGGATATGGGCAAT
GAAATTGACACCCAGAACCGTCAAATTGATCGCATCATGGAAAAAGCCGACTCTAATAAAACCCGTATTGATGAA
GCGAACCAGCGCGCCACGAAAATGCTGGGTTCCGGCCGTATCCATCGTCCGGTGGCAACGATGGTGTCAAAAGGC
GAAGAACTGTTTACGGGTGTTGTCCCGATTCTGGTTGAACTGGATGGCGACGTCAATGGTCACAAATTCAGTGTT
TCCGGTGAAGGCGAAGGTGATGCAACCTACGGCAAACTGACGCTGAAATTTATCTGCACCACCGGTAAACTGCCG
GTGCCGTGGCCGACCCTGGTTACCACGTTTTCTTATGGCGTTATGGTCTTCGCCCGTTACCCGGATCACATGAAA
CAGCACGACTTTTTCAAAAGTGCAATGCCGGAAGGCTACGTTCAAGAACGTACCATTTTCTTTAAAGATGACGGT
AACTACAAAACCCGCGCGGAAGTCAAATTCGAAGGCGATACGCTGGTGAATCGTATCGAACTGAAAGGTATCGAT
TTCAAAGAAGACGGCAACATCCTGGGTCATAAACTGGAATATAACTTCAATAGCCACAATGTGTACATTATGGCC
GATAAACAGAAAAATGGTATCAAAGCAAACTTCAAAATCCGCCATAACATCGAAGACGGTGGCGTTCAACTGGCG
GATCACTATCAGCAAAATACCCCGATTGGTGATGGTCCGGTGCTGCTGCCGGATAACCATTACCTGAGCATCCAG
TCTAAACTGAGTAAAGATCCGAATGAAAAACGTGACCACATGGTGCTGCTGGAATTTGTTACGGCGGCGGGTATT
ACGCTGGGTATGGACGAACTGTATAAATGActcgaggatccggctgctaacaaagcccgaaaggaagctgagttg
gctgctgccaccgctgagcaataactagcataaccccttggggcctctaaacgggtcttgaggggttttttgctg
aaaggaggaactatatccggatatcccgcaagaggcccggcagtaccggcataaccaagcctatgcctacagcat
ccagggtgacggtgccgaggatgacgatgagcgcattgttagatttcatacacggtgcctgactgcgttagcaat
ttaactgtgataaactaccgcattaaagcttatcgatgataagctgtcaaacatgagaa
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